Corporate Tax Manager at Acadia Pharmaceuticals

Hoofddorp, North Holland, Netherlands

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

PharmaceuticalsIndustries

Requirements

University degree in Finance, Economics, Tax, or a related field
Dutch tax/accounting qualification or relevant experience with Dutch tax authorities (preferred)
Proven experience in a tax department, either in practice or industry
Hands-on experience with Dutch corporate income tax filings and tax audits
Familiarity with Pillar II and other OECD/EU initiatives (strong plus)
Strong organizational and coordination skills
Ability to communicate effectively with stakeholders
Detail-oriented with a pragmatic approach to prioritization
Proficiency in Excel; experience with tax technologies (plus)
Fluency in English (required); Dutch fluency or proficiency (preferred)

Responsibilities

Own the tracking and monitoring of global tax return filings across the Group
Provide training and advisory support on direct tax matters in various jurisdictions
Coordinate the Group-wide implementation of Pillar II compliance
Stay ahead of OECD/EU tax developments and advise on their impact
Lead, prepare and file Dutch corporate income tax returns, in close collaboration with finance teams
Partner with the Dutch Finance Manager on tax disclosures and reporting for local financial statements
Act as a primary contact for Dutch tax authorities, managing audits with support from local advisors
Contribute to the effective management of direct tax risks and opportunities across the Group
Support the Head of Direct Tax on strategic projects, such as implementation of new tax technology, tax training and guidance for global finance teams, review of IFRS quarterly tax reporting (current and deferred tax), and preparation of annual Group tax provisions

Skills

Dutch Corporate Income Tax

Tax Compliance

Pillar II

OECD Tax

EU Tax

Tax Audits

IFRS Reporting

Tax Risk Management

Tax Technology

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters

1993Year Founded

$813.4MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees